CO177 Major Clinical Events in Patients Who Switched From Warfarin to DOACs: A Real-World Study Based on National Claims Data From the Contributory Regime in Colombia
Gustavo Sánchez Torres(Universidad Nacional de Colombia), A. Mesa, Gustavo Buitrago Hurtado(Universidad Nacional de Colombia), J Arciniegas, JM Reyes Sanchez, N. Castaño Gamboa(Pfizer (United Kingdom))
Cited by 0
Related Papers
Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib
|Clinical Rheumatology|2020|9
PCN210 RESOURCE UTILIZATION AND COST FOR WOMEN WITH ADVANCED HR+/HER2- BREAST CANCER IN COLOMBIAN HEALTH CARE SETTINGS
|Value in Health|2019|6
Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
|Journal of Primary Care & Community Health|2021|3